Easy-to-use hepatitis C self-test for adults
Part of Digestive system, Infections clinical trials.
This study tests a home test for hepatitis C that you can use yourself. It checks if adults can use the test correctly by following the instructions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You can read and follow instructions
- You are not a healthcare professional or lab worker
- You are not currently in another drug or vaccine study
- You do not have vision problems that can't be fixed with glasses or contacts
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is setting up a program to test adults for hepatitis C antibodies using quick, point-of-care tests. It helps confirm how well this testing approach works in real-world care so more people can be identified and treated earlier.
This trial studies point-of-care (on-site) testing to find hepatitis C in adults who are at higher risk. If hepatitis C is found, earlier detection can help you get connected to care sooner.
This study collects basic information from adults who already had a quick, on-site hepatitis C (HCV) test. It aims to improve how point-of-care testing is done and documented, which may lead to faster follow-up and care.
This study looks at how emergency department patients feel about a new, quick test for hepatitis C. If you have tested positive for hepatitis C antibodies but haven't had a follow-up test to confirm an active infection, you might be able to join and share your thoughts on this new testing approach.
This study compares two ways to treat hepatitis C: getting treatment at a local clinic near you, or the usual care at a central hospital. It aims to see if treatment at local clinics is safe, effective, and more convenient for patients.
This study tests a new vaccine designed to prevent hepatitis C, a virus that affects the liver. The goal is to see if the vaccine is safe, and to understand how the body's immune system responds to it.
Hear when a new Hepatitis C trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.